Abstract. A large-scale longitudinal cohort project was initiated in western Kenya in June 1992. Between June 1992 and July 1994, 1,848 children less than 15 years of age were monitored prospectively for a mean of 236 days. During this period, 12,035 blood smears were examined for malaria and only 34% were found to be negative. Parasite prevalence (all species) decreased with age (from a high of 83% among children 1-4 years old to 60% among children 10-14 years old). Even more dramatic decreases were noted in the prevalence of high density falciparum infection (from 37% among children 12-23 months old to Ͻ 1% among 10-14-year-old children) and in clinical malaria (20% to 0.3% in the same age groups). Children Ͻ 1 year of age accounted for 55% of all cases of anemia detected. Anemia was consistently associated with high density infection in children Ͻ 10 years of age (20% to 210% increased risk relative to aparasitemic children). These results demonstrate the relationship between high-density malaria infection and two clinical manifestations of malarial illness.
Presence of a highly efficient vector (Anopheles gambiae), a large rural population, a high degree of mobility, an inadequate health care infrastructure, and intensifying antimalarial drug resistance are all factors that maintain malaria as one of the most important causes of illness and death in most of sub-Saharan Africa. Interventions aimed at reducing this burden of malaria-associated morbidity and mortality are badly needed in sub-Saharan Africa. Because of these and similar factors, facility-based interventions alone will probably not be sufficient to have a significant or sustained impact on morbidity or mortality rates. Barring massive improvements in standards of living or access to high-quality health care, large-scale community-based interventions that either prevent infection, reduce the rate or intensity of exposure, or attenuate the clinical progression to severe disease are most likely the only interventions that will have a significant impact in the foreseeable future.
Before such interventions are adopted and implemented on a wide scale, careful assessment and demonstration of their efficacy and effectiveness is required, as has been the case for insecticide-impregnated bed nets and the SPf66 vaccine. [1] [2] [3] [4] A reliable assessment of the intervention's efficacy, in turn, requires an extensive and thorough understanding of the dynamics and natural history of malaria infection and disease in the area in which they are tested. If the ultimate goal is to develop strategies to decrease morbidity as well as mortality, all potential interventions would benefit from the identification of clinically relevant outcomes or endpoints that could be used to assess the effect of the intervention on morbidity. The development of insecticide-impregnated bed net or similar vector-avoidance interventions would benefit from an increased understanding of the relationship between exposure and disease. The vaccine development process would benefit from an improved understanding of how immunity is acquired under natural conditions and how it influences the development and expression of illness.
To develop a site in which an in-depth and comprehensive understanding of the natural history of malaria and the development and expression of naturally acquired immunity could be obtained, the Asembo Bay Cohort Project was initiated in July 1992 in western Kenya. The primary goals of this study were to describe the epidemiology of malaria, to characterize factors associated with acquisition of malaria infection, to investigate the determinants of progression from infection to disease, and to investigate the acquisition of acquired immunity to malaria. The study incorporated a prospective design to allow inference of causality and a long duration follow-up to capture events occurring throughout the period of transition from the immunologic naivety of infancy to the relative immunity of late childhood. Additionally, a multidisciplinary approach allowed for the simultaneous collection of a wide variety of epidemiologic, entomologic, and immunologic data from the same population over time.
This paper describes some of the fundamental parameters of malaria infection and disease as it was experienced by the resident population during the first two years of the study.
METHODS
A detailed description of the methods used in this project is presented in a companion paper. 5 Briefly, pregnant women were identified during monthly census of all residents of the 15 participating villages in the Asembo Bay area of western Kenya. Women giving informed consent to participate were enrolled and visited at home by village monitors once per month during the woman's pregnancy. At each visit the village monitors administered a standardized questionnaire that collected information regarding illnesses occurring since the last visit, symptoms experienced, use of health care facilities, and use of medicines. Axillary temperatures, thick and thin blood smears for malaria parasitemia, and capillary blood samples for hemoglobin determination and immunologic studies were also obtained at each visit.
Both mother-infant pairs and direct siblings of the infant less than 15 years of age were visited by the village monitors within two weeks of birth and then every two weeks there-after. At each visit, questionnaires that collected information as described above were administered for each individual, with information regarding an infant's or child's health being recounted by the mother or other adult guardian. Axillary temperatures were also obtained using digital thermometers at each visit. Once per month, capillary blood samples and thick and thin blood smears were obtained from all participants. Any participant with documented fever (axillary temperature Ն 37.5ЊC) and malaria parasitemia received a treatment dose of pyrimethamine/ sulfadoxine (Fansidar; F. Hoffman LaRoche, Basel, Switzerland). The village monitors were available to take temperatures and blood smears at any time between regularly scheduled visits for any participant who thought that he/she or a child was ill. Severe malaria, non-malarial illnesses, or illnesses judged to require more than antimalarial treatment were referred to local health facilities.
Blood smears were stained with Giemsa and quantified using standard methods. Briefly, the number of asexual parasites per 300 leukocytes were counted and a final density was calculated using an assumed leukocyte count of 8,000/ mm 3 . Hemoglobin concentrations were measured using the HemoCue system (HemoCue, Anglholm, Sweden). 6 Optimal case definitions of clinical malaria were identified for specific age groups (0-5 months, 6-11 months, 12-23 months, 24-35 months, 36-47 months, 48-59 months, 5-9 years, 10-4 years, Ն15 years not pregnant, and Ն 15 years pregnant) and for all age groups combined. In general, clinical malaria was defined as a measured axillary temperature Ն 37.5ЊC in the presence of malaria parasitemia greater than or equal to the critical density for the given age group. Methods for identifying the best critical density to use in devising case definitions for clinical malaria in areas where the prevalence of malaria parasitemia is high have been outlined by researchers working at other sites in Africa. 7, 8 Briefly, a logistic regression model was fitted using a two-parameter curve, f(x) ϭ B(xi)t where f(x) is the presence or absence of a measured fever and x is the parasite density. The model incorporates longitudinal data analysis techniques (generalized estimating equations) to allow for the correlation that exists between repeat observations over time for the same individual. The attributable fraction, the proportion of fever outcomes attributable to malaria parasitemia, for each age group was computed using previously described methods. 7 The sensitivity and specificity of potential definitions were calculated for parasite densities in 500 parasite increments. The critical density was defined as the parasite density at which both sensitivity and specificity was maximized. Only pure Plasmodium falciparum infections were used to define critical densities.
Malaria infection was defined as a parasitemia of any density diagnosed by light microscopy. Parasite densities were categorized into negative, low density, and high density. Low density infections were infections with a density below the critical density defining clinical malaria and high density infections were infections with a density at or above the critical density. Except where specifically noted, results are presented in terms of definitions based on age-specific critical densities rather than the overall critical density. Where a species of Plasmodium is not specifically noted, parasitemia refers to any infecting Plasmodium species. Fever was defined as a measured axillary temperature Ն 37.5ЊC using a digital centigrade thermometer.
For participants six months of age or older, anemia was defined as a hemoglobin concentration of less than 11.0 g/ dl, as recommended by the World Health Organization (Geneva, Switzerland) 9 and the Centers for Disease Control and Prevention (CDC). 10 For participants less than six months of age, anemia was defined as a hemoglobin concentration more than two standard deviations below the mean of a similarly aged infant from an unexposed referent population. 11 For the purposes of calculating prevalence, a participant was counted as having a particular condition (e.g. malaria infection, fever, or anemia) if that participant had the condition at any time during a given month (i.e., ever positive or ever febrile for a given month); multiple events occurring in the same individual during the same time period (e.g., a participant having two positive blood smears in a given month) were counted as a single event. Denominators used in calculating prevalence rates consisted of all participants of a given age group or category who were evaluated for a particular condition during a given time period.
This study was approved by the Ethical Review Board of the Kenya Medical Research Institute (KEMRI) and CDC.
RESULTS
During the period of June 1992, and July 1994, the mean (range) number of participants visited in any given month was 167 (0-273) for children less than one year of age, 161 (0-310) for children between one and four 4 years of age, 107 (0-265) for children between five and nine years of age, and 54 (0-136) for children between 10 and 14 years of age. For 1,848 children with at least one routine visit made after the birth of the infant, the mean duration of follow-up was 236 days (SD ϭ 168); 988 (54%) were monitored for Ն six months and 390 (21%) were monitored for Ն 12 months.
Of 12,035 blood smears obtained from participating children during the first two years of the study, only 34.2% of the blood smears obtained were negative for malaria parasites. Overall, 88.3% of the blood smears exhibited a pure P. falciparum infection, 2.1% were P. malariae, 1.2% were P. ovale, 6.2% were mixed infections of P. falciparum and P. malariae, and 2.2% were mixed infections of P. falciparum and P. ovale. The distribution of malaria species varied slightly with age; older children were more likely to have mixed P. falciparum/P. malariae infections than were children less than one year of age or adult women.
The overall geometric mean parasite densities (GMPDs) of P. falciparum for each age group are shown in Figure 1 . Mean parasite density increased from birth, peaking among children 6-11 months of age, and decreased dramatically with age. The GMPDs for infections categorized as being low or high (based on age-specific critical densities) are shown in Table 1 and show an increasing ability to limit both high and low parasite densities with age. As expected, the overall GMPD for P. falciparum infections (GMPD ϭ 1,561, 95% confidence interval [CI] ϭ 1,497-1,628) was significantly higher than that for either P. malariae (GMPD ϭ 762, 95% CI ϭ 623-932, P Ͻ 0.001) or P. ovale (GMPD ϭ 607, 95% CI ϭ 444-829, P Ͻ 0.001).
Critical densities, case definitions of clinical malaria, and attributable fractions. For all age groups combined, a case definition of clinical malaria based on a single critical density of 4,000 asexual P. falciparum parasites/mm 3 had a sensitivity of 81.1% and a specificity of 82.3%. Age-specific analysis, however, showed a wide range of parasite densities that maximized sensitivity and specificity, ranging from a low of 500 parasites/mm 3 for children 10-14 years old to a high of 7,000 for children 12-35 months old ( Table 1) . The low critical densities for the older age groups (Ͼ 5 years) are potentially misleading and reflect the infrequent occurrence of either higher density infections or fevers rather than a decreased fever threshold.
P. falciparum parasite prevalence. Only minimal seasonal variations were noted in parasite prevalence (Figure 2) . The overall average monthly parasite prevalence was 42% and 73% for infants less than six old and 6-11 months old, respectively. Among older children, there was a small but progressive decrease in parasite prevalence with age ( Figure   3 , open bars). The overall average monthly parasite prevalence was 83% among children 1-4 years old, 75% among children 5-9 years old, and 60% among children 10-14 years old. A more dramatic decrease was observed in the prevalence of high density infections (Figure 3 , stippled bars). While the average monthly prevalence of high density infection was highest among children 6-11 months old (39.1%), it decreased to only 2% among children 10-14 years of age. The mean monthly prevalence of high density infection among infants less than six months old was 18.6%.
Fever. Fever prevalence exhibited greater seasonal variation, with peaks in documented febrile illness following months with high rainfall (Figure 4) . As with parasite prevalence, mean monthly fever prevalence decreased with age from 32% among children 6-11 months of age to 5% among 10-14 year-old children ( Figure 5 , open bars). The average monthly prevalence of fever was 20.6% among infants less than six months of age. Incidence density ratios (IDRs) of episodes of fever demonstrated significantly increased risk among younger-aged children, which decreased with age from a high of 6.1 times among children 6-11 months of age to 1.4 times among children 5-9 years of age compared with children 10-14 years of age (P Յ 0.01 for all age groups, Table 2 ).
Clinical malaria. The specifics of the case definitions used are presented in Table 1 . The average monthly prevalence of clinical malaria (axillary temperature Ն 37.5ЊC in the presence of a Plasmodium sp. parasite density greater than or equal to the critical density) varied from nearly 20% among children 6-11 months old to 0.3% among children 10-14 years old ( Figure 5 , stippled bars). Pure P. falciparum infections accounted for more than 95% of infections classifiable as clinical malaria; the remainder were primarily mixed infections where P. falciparum was one of the infecting species.
Among children infected with P. falciparum, the percentage of infections that were definable as clinical malaria was also highest for children less than one year of age (27.8% and 27.9% for children less than six months of age and children 6-11 months of age, respectively). This percentage decreased to 19.6% among children 12-23 months of age and continued to decrease progressively with age to 3.6% among children 10-14 years old. As with fever, the IDR for clinical P. falciparum malaria varied significantly with age (Table  2 ). Children 6-11 months old had a 12-fold increased risk of clinical P. falciparum malaria referent to children 10-14 years of age (P Ͻ 0.001). This risk diminished to an approximately three-fold increase in risk among children 3-4 years of age (P Ͻ 0.001). Risk of clinical malaria among children 5-9 years of age did not differ significantly from the older children.
Additionally, all age groups had roughly a two-fold increase in the risk of fever associated with high density infections relative to low density infection; the risk of fever associated with a high density infection (relative to risk of fever without parasitemia) generally decreased with age from 5.5 for children 12-23 months of age to 1.7 for children 10-14 years of age (Table 3) . Only children less than 23 months of age had a significant risk of fever associated with low density infections.
Anemia. Although anemia was highly prevalent in this population (Figure 6 ), severe anemia, defined as a hemoglobin concentration Ͻ 5 g/dl, was fairly rare in the community, being identified only 98 times in 12,397 person-months of observation (incidence density ϭ 7.9/1,000 person-months, or 0.8% of observations). Children less than one year of age accounted for 55% (54 of 98) of the cases of severe anemia. Children 6-11 months of age experienced the greatest burden of anemia; on average, more than 80% of the children in this age group were at least mildly anemic. While the prevalence of anemia decreased with age, it was only in the two oldest age groups (children between 5 and 14 years of age) that anemia was the exception rather than the rule.
Among children less than five years of age, anemia was always more prevalent among parasitemic children than aparasitemic children (Figure 7 ). The prevalence of anemia was high even among children who were not parasitemic at the time of hemoglobin measurement. Approximately 60% of the aparasitemic children between the ages of six and 35 months were anemic (note that these are point prevalences and do not take into consideration the possibility of recently treated malaria infection). Among children less than 10 years of age, high density malaria infection was consistently associated with anemia (20% to 210% increase in risk relative to aparasitemic children, depending upon age; P Յ 0.01; Table 4 ). Low density infection was associated with anemia only for children less than five years of age (20% to 120% increase in risk relative to aparasitemic children, depending upon age; P Ͻ 0.05). Also depending upon age group, the fraction of anemia attributable to parasitemia was 10-18% for low density infections and 9-36% for high density infections.
DISCUSSION
This analysis highlights the changing relationships between parasite density and the primary clinical manifestations of malarial illness in this area, that is, fever and anemia. On a population basis, acquisition of immunity to malaria in this high transmission area appears to manifest itself initially as an increasing ability to limit the density of malaria parasites, through progressive decreases in mean parasite density and decreased occurrence of high density infections. This ability to limit the occurrence of high density infections is apparent in children as young as one year of age and continues until high density infections are a fairly rare phenomenon. As children enter their third year, they begin to develop an ability to not only significantly reduce the occurrence of high density infection, but also to reduce the occurrence of any density infection; by the time children are between 10 and 14 years of age, the average monthly parasite prevalence, while still relatively high at 60%, is much less than the nearly 90% experienced by children in younger age groups. At the same time, there appears to be an acquired ability to tolerate parasites without fever. After FIGURE 7 . Prevalence of anemia by parasite density group and age. Anemia is age-adjusted (see Methods). Parasite groups: open bars ϭ negative; stippled bars ϭ low density parasitemia (positive but density less than the cutoff value for age group); striped bars ϭ high density parasitemia (density greater than or equal to the cutoff value for age group). Vertical lines are 95% confidence interval around the prevalence estimate. m ϭ months; y ϭ years. --* Anemia is age-adjusted (see Methods). Risk ratios (RR) and 95% confidence intervals (95% CI) are all referent to negative parasite density within age groups. Population attributable fractions (AFP), the proportion of anemia attributable to exposure to either high or low malaria parasite density, are given for significant associations.
24 months of age, there is no significant increase in risk of fever given a low density infection. Additionally, there is a dramatic decrease in the risk of fever given the high density infection that occurs at the same time (from a five-fold increase for children Ͻ 24 month of age to a two-fold increase for children 24-35 months of age), followed by a continued but slight decrease during the rest of childhood. These estimates of risk of fever given varying levels of parasitemia compare well with data from a previous study of children in this same general area. 12 A similar situation was seen with anemia, an important manifestation of malaria infection in this area of Kenya. Parasitemia had the greatest impact on the hematologic status of children less than six months of age. Between six months and four years of age, the increased risk of anemia due to either high or low density infection was uniform. High density infections still were associated with increased risk of anemia for children 5-9 years old, but after 10 years, there was no significant increase in risk given either level of parasitemia. As with fever, there appears to be an increasing ability to limit the hematologic effects of malaria infection that is developed over time and, probably, cumulative exposure. The youngest children lack the ability to maintain hematologic status in the face of any density malaria infection. With age, they appear to develop the ability to limit the effects of low density infections first, then ultimately to limit the effects of high density infections as well. It is important to note, however, that parasitemia continues to have hematologic consequences long after it loses its association with fever.
A number of strategies have been investigated or are in development to reduce the burden of malaria disease, including improved case management of both malaria illness and anemia, use of insecticide-impregnated bed nets, and vaccines. [13] [14] [15] In this area and probably most of sub-Saharan Africa, disease control strategies must be designed to be usable in the groups at highest risk, specifically young children. In this western Kenyan community, the ages exhibiting the greatest burden of malaria illness were, in general, children less than five years of age and specifically those less than two years of age.
These results may also help to explain the success or failure of specific interventions. For example, the reduction in mortality attributed to insecticide-impregnated bed net use may be directly associated with the reduction of the incidence of higher density parasitemia. [16] [17] [18] Even in areas where drug-resistant malaria occurs, if a drug still has the ability to reduce parasite loads there may be decreases in illness and/ or mortality. 19 A note of caution, however, is required; in this population, there was a significant risk of anemia even among children with low density infections. Because low density infections were not significantly associated with fever among children more than two years of age, inadequate treatment (or potentially any other intervention, such as vaccines), which limits parasite densities without eliminating them, may actually increase the proportion of children with clinically silent malaria infections who may go on to develop severe anemia. It is clearly important, therefore, to consider the potential for deleterious effects of interventions as well as the benefits.
It is clear that effective malaria prevention strategies are desperately needed in Africa. With a better understanding of the dynamics between parasitemia, age, and clinical expression of malarial disease, potential pitfalls of new strategies and technologies can be anticipated and modifications in design or implementation can be made. In this way, strategies that make sense given what is known about the clinical epidemiology of malaria can be identified and moved forward efficiently and begin to decrease the burden of malaria in Africa.
